Search

Four best-performing Top Picks for 2011 are reviewed by Dick Davis Digests’ Editor Chloe Lutts.

As the new year approaches, we’re reviewing the past year’s worth of Investment of the Week and Dick Davis Digests. This week, I’m going to spotlight the year’s best-performing Top Picks. Every year, we ask all of our Digest contributors to send us a recommendation of their single favorite stock to own...

Here’s one questions from a reader: How should I develop my portfolio for retirement?

Here are four step-by-step instructions on stock investing from the American Association of Individual Investors.

I have no idea if the biotech sector is near a bottom, but based on history, it would seem that we’re within 10% or so of that mark. The greatest risk seems to be that the binary outcome possibilities for developmental-stage biotech stocks (either fail or succeed) don’t mesh with investors’ risk appetite right now.

Interest rates are finally dropping and a new era has begun, and these two dividend-paying stocks are ideal for the changing times.

The past week was relatively subdued in small-cap land; the asset class, as measured by the S&P 600 Small Cap Index, dropped a modest 0.8%. The biggest declines were seen in the energy, consumer discretionary and healthcare sectors. The latter is likely due to disruption from Hurricane Maria and renewed chatter about reducing federal subsidies that were part of the Affordable Care Act (ACA).

It’s been a very news-filled week, with a dockworkers strike (and short-term settlement) along with the Middle East attacks (and fears of an upcoming reprisal) and the usual spate of economic reports—but, interestingly, there hasn’t been that much movement. Taking into account pre-market action (before the jobs report), most big-cap indexes are flat-ish on the week, though smaller-cap names are down more than 1%.

Buying and holding stocks for the long term is a good way to build wealth for retirement. It’s also a good way to pay less taxes.

Rising AI and EV electricity demand, as well as growing exports, are fueling a natural gas boom and opening strong long-term opportunities across the energy sector.

If you’ve ever been tempted by the stories and claims about day trading – don’t be. Here’s why day trading isn’t something that we recommend at Cabot.

The recently-rumored merger between semiconductor companies Marvell Technology Group (MRVL – yield 1.2%) and Cavium (CAVM) was announced this morning.

While people in the U.S. are familiar with Aflac, Inc.’s (AFL, NYSE) memorable (if not annoying) “duck” mascot, most Americans would likely be surprised to know that the company actually does most of its business in Japan. Aflac is the world’s largest underwriter of supplemental cancer insurance, with the largest...

Regarding the here and now, we’re starting to see signals that we could have a market dip, which would be entirely normal given that it’s only had two small retreats since stocks began racing higher in September.

This month we’re adding a small company that specializes in the opaque and inefficient market for selling surplus and salvaged goods.

The company has a market cap of just $580 million and is growing revenue and EPS by double digits. It’s an interesting setup, especially as government agencies and corporations increasingly look to save money and achieve sustainability goals.

All the details are inside this month’s Issue.

With growth stocks suffering, value and income are at a premium as we head into 2022. This emerging markets ETF provides both.